Exact Sciences to participate in November investor conferences
Exact Sciences Corp. (Nasdaq: EXAS) announced its participation in three upcoming healthcare conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Exact Sciences Corp. (Nasdaq: EXAS) announced its participation in three upcoming healthcare conferences. These include a fireside chat at the Jefferies London Healthcare Conference on November 16, 2021, at 10:40 a.m. ET; the Stifel Virtual Healthcare Conference on the same day at 3:20 p.m. ET; and the Evercore ISI HealthCONx Virtual Conference on November 30, 2021, at 11:20 a.m. ET. Investors can access webcasts of these events on the company's investor relations website.
Details
News Market Reaction – EXAS
The recorded move for EXAS in the trading session of this news was +2.33%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MADISON, Wis., Nov. 1, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participate by webcast.
- Jefferies London Healthcare Conference
Fireside Chat on Tuesday, November 16, 2021 at 10:40 a.m. ET
- Stifel Virtual Healthcare Conference
Fireside Chat on Tuesday, November 16, 2021 at 3:20 p.m. ET
- Evercore ISI HealthCONx Virtual Conference
Fireside Chat on Tuesday, November 30, 2021 at 11:20 a.m. ET
The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-november-investor-conferences-301412721.html
SOURCE Exact Sciences Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.